Transcriptional Effects of ApoE4: Relevance to Alzheimer’s Disease

[1]  D. Bredesen,et al.  Downregulation of protein phosphatase 2A by apolipoprotein E: Implications for Alzheimer's disease , 2017, Molecular and Cellular Neuroscience.

[2]  J. Kordower,et al.  Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins , 2017, Acta Neuropathologica.

[3]  D. Holtzman,et al.  Apolipoprotein E and Alzheimer’s disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins , 2017, Journal of Lipid Research.

[4]  Thomas C. Südhof,et al.  ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Aβ Secretion , 2017, Cell.

[5]  R. Urfer,et al.  Identification of a Nuclear Respiratory Factor 1 Recognition Motif in the Apolipoprotein E Variant APOE4 linked to Alzheimer’s Disease , 2017, Scientific Reports.

[6]  Fan Liao,et al.  Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease , 2016, Current opinion in lipidology.

[7]  G. Chételat,et al.  Relative effect of APOE ε4 on neuroimaging biomarker changes across the lifespan , 2016, Neurology.

[8]  M. Pellegrini,et al.  Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on ω-3 supplementation , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  M. Leissring.  Aβ-Degrading Proteases: Therapeutic Potential in Alzheimer Disease , 2016, CNS Drugs.

[10]  Dale E. Bredesen,et al.  Reversal of cognitive decline in Alzheimer's disease , 2016, Aging.

[11]  Alzheimer’s Association,et al.  2016 Alzheimer's disease facts and figures , 2016, Alzheimer's & Dementia.

[12]  M. Galsky,et al.  All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase , 2016, The FEBS journal.

[13]  D. Bredesen,et al.  Direct Transcriptional Effects of Apolipoprotein E , 2016, The Journal of Neuroscience.

[14]  S. An,et al.  Role of apolipoprotein E in neurodegenerative diseases , 2015, Neuropsychiatric disease and treatment.

[15]  D. Alkon,et al.  ApoE4 and Aβ Oligomers Reduce BDNF Expression via HDAC Nuclear Translocation , 2015, The Journal of Neuroscience.

[16]  Hyuk Cho,et al.  Evolutionary Analysis of the B56 Gene Family of PP2A Regulatory Subunits , 2015, International journal of molecular sciences.

[17]  R. Mahley,et al.  Apolipoprotein E: Structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases , 2014, Neurobiology of Disease.

[18]  Hye Rin Lee,et al.  Cilostazol suppresses β‐amyloid production by activating a disintegrin and metalloproteinase 10 via the upregulation of SIRT1‐coupled retinoic acid receptor‐β , 2014, Journal of neuroscience research.

[19]  G. D. Griffin,et al.  Neuroprotective effects of resveratrol in Alzheimer disease pathology , 2014, Front. Aging Neurosci..

[20]  R. Kaufman,et al.  The impact of the endoplasmic reticulum protein-folding environment on cancer development , 2014, Nature Reviews Cancer.

[21]  G. Bu,et al.  The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer’s disease , 2014, Front. Aging Neurosci..

[22]  G. Alexander,et al.  Exercise, APOE genotype, and the evolution of the human lifespan , 2014, Trends in Neurosciences.

[23]  J. Sontag,et al.  Protein phosphatase 2A dysfunction in Alzheimer’s disease , 2014, Front. Mol. Neurosci..

[24]  D. Sinclair,et al.  Small molecule SIRT1 activators for the treatment of aging and age-related diseases. , 2014, Trends in pharmacological sciences.

[25]  L. Guarente,et al.  SIRT1 in Neurodevelopment and Brain Senescence , 2014, Neuron.

[26]  L. Carboni,et al.  Human apolipoprotein E4 modulates the expression of Pin1, Sirtuin 1, and Presenilin 1 in brain regions of targeted replacement apoE mice , 2014, Neuroscience.

[27]  D. Bredesen,et al.  Neuroprotective Sirtuin ratio reversed by ApoE4 , 2013, Proceedings of the National Academy of Sciences.

[28]  G. Casadesus,et al.  Dietary resveratrol prevents Alzheimer’s markers and increases life span in SAMP8 , 2013, AGE.

[29]  P. Murali Doraiswamy,et al.  Mapping the effects of ApoE4, age and cognitive status on 18F-florbetapir PET measured regional cortical patterns of beta-amyloid density and growth , 2013, NeuroImage.

[30]  T. Rohn.  Proteolytic Cleavage of Apolipoprotein E4 as the Keystone for the Heightened Risk Associated with Alzheimer’s Disease , 2013, International journal of molecular sciences.

[31]  E. Rassart,et al.  Binding and Repressive Activities of Apolipoprotein E3 and E4 Isoforms on the Human ApoD Promoter , 2013, Molecular Neurobiology.

[32]  A. Shah,et al.  ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions , 2013, Proceedings of the National Academy of Sciences.

[33]  A. Dey,et al.  Sirtuin1: A Promising Serum Protein Marker for Early Detection of Alzheimer’s Disease , 2013, PloS one.

[34]  Cornelia M. Wilson,et al.  Tau protein phosphatases in Alzheimer's disease: The leading role of PP2A , 2013, Ageing Research Reviews.

[35]  Jie Li,et al.  Differential Regulation of Amyloid-β Endocytic Trafficking and Lysosomal Degradation by Apolipoprotein E Isoforms*♦ , 2012, The Journal of Biological Chemistry.

[36]  Isabelle Cournu-Rebeix,et al.  Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects , 2012, Journal of Medical Genetics.

[37]  Anatol C. Kreitzer,et al.  Hilar GABAergic Interneuron Activity Controls Spatial Learning and Memory Retrieval , 2012, Alzheimer's & Dementia.

[38]  A. Jaeschke,et al.  Apolipoprotein E4 Impairs Macrophage Efferocytosis and Potentiates Apoptosis by Accelerating Endoplasmic Reticulum Stress* , 2012, The Journal of Biological Chemistry.

[39]  M. Nalls,et al.  A large study reveals no association between APOE and Parkinson's disease , 2012, Neurobiology of Disease.

[40]  Y. Pi,et al.  Association between apolipoprotein E gene polymorphism and the risk of vascular dementia: A meta-analysis , 2012, Neuroscience Letters.

[41]  I. Ferrer,et al.  PP2A and Alzheimer disease. , 2012, Current Alzheimer research.

[42]  C R Jack,et al.  Spotlight on the January 24 Issue , 2012, Neurology.

[43]  G. Landreth,et al.  Apolipoprotein E Promotes β-Amyloid Trafficking and Degradation by Modulating Microglial Cholesterol Levels* , 2011, The Journal of Biological Chemistry.

[44]  L. Jungbauer,et al.  Introducing Human APOE into Aβ Transgenic Mouse Models , 2011, International journal of Alzheimer's disease.

[45]  C. Brayne,et al.  Microarray analysis of the astrocyte transcriptome in the aging brain: relationship to Alzheimer's pathology and APOE genotype , 2011, Neurobiology of Aging.

[46]  Yadong Huang,et al.  Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer's disease: lessons from ApoE mouse models. , 2011, Biochemical Society transactions.

[47]  K. Bales,et al.  Reduced levels of human apoE4 protein in an animal model of cognitive impairment , 2011, Neurobiology of Aging.

[48]  D. Holtzman,et al.  Apolipoprotein E in Alzheimer's disease and other neurological disorders , 2011, The Lancet Neurology.

[49]  V. Haroutunian,et al.  Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy , 2010, Neuron.

[50]  O. Kwon,et al.  Apolipoprotein E epsilon 4 allele is not associated with age at onset or MMSE of Parkinson's disease in a Korean study. , 2010, Parkinsonism & related disorders.

[51]  Yadong Huang,et al.  Apolipoprotein E4 Causes Age- and Tau-Dependent Impairment of GABAergic Interneurons, Leading to Learning and Memory Deficits in Mice , 2010, The Journal of Neuroscience.

[52]  V. Haroutunian,et al.  Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy , 2010, Neuron.

[53]  R. Mann,et al.  Origins of specificity in protein-DNA recognition. , 2010, Annual review of biochemistry.

[54]  S. Misaghi,et al.  Prolonged endoplasmic reticulum stress promotes mislocalization of immunoglobulins to the cytoplasm. , 2010, Molecular immunology.

[55]  D. Pozo,et al.  Activity-Dependent Neuroprotective Protein (ADNP) Expression in the Amyloid Precursor Protein/Presenilin 1 Mouse Model of Alzheimer’s Disease , 2010, Journal of Molecular Neuroscience.

[56]  Maria C. Norton,et al.  Association between APOE ε4 Allele and Vascular Dementia: The Cache County Study , 2010, Dementia and Geriatric Cognitive Disorders.

[57]  Jeremy M Berg,et al.  Probing the DNA-binding affinity and specificity of designed zinc finger proteins. , 2010, Biophysical journal.

[58]  A. Fagan,et al.  APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging , 2010, Annals of neurology.

[59]  R. Mahley,et al.  GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice. , 2009, Cell stem cell.

[60]  E. Weeber,et al.  ApoE4 Decreases Spine Density and Dendritic Complexity in Cortical Neurons In Vivo , 2009, The Journal of Neuroscience.

[61]  Jin-Moo Lee,et al.  Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide , 2009, Proceedings of the National Academy of Sciences.

[62]  Zhao Wang,et al.  ApoE 4 reduces the expression of Aβ degrading enzyme IDE by activating the NMDA receptor in hippocampal neurons , 2009, Neuroscience Letters.

[63]  T. Kilpatrick,et al.  Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy , 2009, Neurology.

[64]  R. Mann,et al.  The role of DNA shape in protein-DNA recognition , 2009, Nature.

[65]  Carol A. Colton,et al.  APOE genotype-specific differences in the innate immune response , 2009, Neurobiology of Aging.

[66]  K. Weisgraber,et al.  Apolipoprotein E4 Domain Interaction Induces Endoplasmic Reticulum Stress and Impairs Astrocyte Function* , 2009, The Journal of Biological Chemistry.

[67]  D. Bredesen.  Neurodegeneration in Alzheimer's disease: caspases and synaptic element interdependence , 2009, Molecular Neurodegeneration.

[68]  F. Liu,et al.  Macrophage-Mediated Degradation of β-Amyloid via an Apolipoprotein E Isoform-Dependent Mechanism , 2009, The Journal of Neuroscience.

[69]  E. Tolosa,et al.  Lack of association of APOE and tau polymorphisms with dementia in Parkinson’s disease , 2008, Neuroscience Letters.

[70]  Katie Hamm,et al.  apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. , 2008, The Journal of clinical investigation.

[71]  C. Kelche,et al.  Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks , 2008, Behavioural Brain Research.

[72]  M. Leissring.  The AβCs of Aβ-cleaving Proteases* , 2008, Journal of Biological Chemistry.

[73]  D. Holtzman,et al.  ApoE Promotes the Proteolytic Degradation of Aβ , 2008, Neuron.

[74]  V. Janssens,et al.  PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail). , 2008, Trends in biochemical sciences.

[75]  D. Elliott,et al.  Analysis of apolipoprotein E nuclear localization using green fluorescent protein and biotinylation approaches. , 2008, The Biochemical journal.

[76]  C. Pietrzik,et al.  Functional role of lipoprotein receptors in Alzheimer's disease. , 2008, Current Alzheimer research.

[77]  T. Vollmer,et al.  APOE ε4 allele is associated with cognitive impairment in patients with multiple sclerosis , 2008, Neurology.

[78]  N. Nalivaeva,et al.  New Insights into the Roles of Metalloproteinases in Neurodegeneration and Neuroprotection , 2007, International Review of Neurobiology.

[79]  T. Morgan,et al.  Systemic inflammation, infection, ApoE alleles, and Alzheimer disease: a position paper. , 2007, Current Alzheimer research.

[80]  G. Koutsis,et al.  APOE ε4 is associated with impaired verbal learning in patients with MS , 2007, Neurology.

[81]  D. Holtzman,et al.  Apolipoprotein E and Low Density Lipoprotein Receptor-related Protein Facilitate Intraneuronal Aβ42 Accumulation in Amyloid Model Mice* , 2006, Journal of Biological Chemistry.

[82]  Wing Sze Cheung,et al.  Apolipoprotein E ε4 Allele Is Associated with Vascular Dementia , 2006, Dementia and Geriatric Cognitive Disorders.

[83]  C. Wijmenga,et al.  Characterization of COMMD protein–protein interactions in NF-κB signalling , 2006 .

[84]  I. Cohen,et al.  NAP, a Peptide Derived from the Activity‐Dependent Neuroprotective Protein, Modulates Macrophage Function , 2006, Annals of the New York Academy of Sciences.

[85]  M. Christiansen,et al.  The association between apolipoprotein E and multiple sclerosis , 2006, European journal of neurology.

[86]  R. Mahley,et al.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[87]  C. Kelche,et al.  Human apoE targeted replacement mouse lines: h-apoE4 and h-apoE3 mice differ on spatial memory performance and avoidance behavior , 2005, Behavioural Brain Research.

[88]  Tian-Li Wang,et al.  Apolipoprotein E is required for cell proliferation and survival in ovarian cancer. , 2005, Cancer research.

[89]  D. Bredesen,et al.  Misfolded proteins, endoplasmic reticulum stress and neurodegeneration. , 2004, Current opinion in cell biology.

[90]  C. Caltagirone,et al.  Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis , 2004, Journal of Neurology.

[91]  S. Speciale,et al.  Altered Expression Levels of the Protein Phosphatase 2A ABαC Enzyme Are Associated with Alzheimer Disease Pathology , 2004, Journal of neuropathology and experimental neurology.

[92]  B. Garner,et al.  Induction of fibroblast apolipoprotein E expression during apoptosis, starvation-induced growth arrest and mitosis. , 2004, The Biochemical journal.

[93]  Tony Wyss-Coray,et al.  Neuron-Specific Apolipoprotein E4 Proteolysis Is Associated with Increased Tau Phosphorylation in Brains of Transgenic Mice , 2004, The Journal of Neuroscience.

[94]  Carol A. Miller,et al.  Down-regulation of DENN/MADD, a TNF receptor binding protein, correlates with neuronal cell death in Alzheimer's disease brain and hippocampal neurons , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[95]  D. Holtzman,et al.  Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients , 2003, Neuroscience.

[96]  K. Blennow,et al.  Measurement of α- and β-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients , 2003, Experimental Neurology.

[97]  L. Mucke,et al.  Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[98]  F. Pfrieger,et al.  Cholesterol homeostasis and function in neurons of the central nervous system , 2003, Cellular and Molecular Life Sciences CMLS.

[99]  R. Montironi,et al.  Apolipoprotein E expression in localized prostate cancers. , 2003, International journal of oncology.

[100]  S. Nisole,et al.  The Anti-HIV Cytokine Midkine Binds the Cell Surface-expressed Nucleolin as a Low Affinity Receptor* , 2002, The Journal of Biological Chemistry.

[101]  M. Hirai,et al.  Nuclear Targeting by the Growth Factor Midkine , 2002, Molecular and Cellular Biology.

[102]  R. Mahley,et al.  Apolipoprotein E4 Potentiates Amyloid β Peptide-induced Lysosomal Leakage and Apoptosis in Neuronal Cells* , 2002, The Journal of Biological Chemistry.

[103]  R. Mahley,et al.  Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[104]  Nicholas M. Luscombe,et al.  Amino acid?base interactions: a three-dimensional analysis of protein?DNA interactions at an atomic level , 2001, Nucleic Acids Res..

[105]  Jonathan D. Smith,et al.  Astrocytes down‐regulate neuronal β‐amyloid precursor protein expression and modify its processing in an apolipoprotein E isoform‐specific manner , 2001, European Journal of Neuroscience.

[106]  B. Winblad,et al.  Effects of apolipoprotein E (apoE) isoforms, β-amyloid (Aβ) and apoE/Aβ complexes on Protein Kinase C-α (PKC-α) translocation and amyloid precursor protein (APP) processing in human SH-SY5Y neuroblastoma cells and fibroblasts , 2001, Neurochemistry International.

[107]  T. Saido,et al.  Metabolic Regulation of Brain Aβ by Neprilysin , 2001, Science.

[108]  J. Trojanowski,et al.  PP2A mRNA Expression Is Quantitatively Decreased in Alzheimer's Disease Hippocampus , 2001, Experimental Neurology.

[109]  Johnm . Taylor,et al.  Two Distal Downstream Enhancers Direct Expression of the Human Apolipoprotein E Gene to Astrocytes in the Brain , 2001, The Journal of Neuroscience.

[110]  L. Panin,et al.  Detection of Apolipoprotein A-I, B, and E Immunoreactivity in the Nuclei of Various Rat Tissue Cells , 2000, Biochemistry (Moscow).

[111]  I. Tesseur,et al.  Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord. , 2000, The American journal of pathology.

[112]  B T Hyman,et al.  Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. , 2000, The American journal of pathology.

[113]  A. Fagan,et al.  Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model , 2000, Annals of neurology.

[114]  A Rostagno,et al.  Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides. , 2000, The Biochemical journal.

[115]  C. Plata-salamán,et al.  Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.

[116]  A. Hofman,et al.  APOE and the risk of PD with or without dementia in a population-based study , 2000, Neurology.

[117]  A. Fagan,et al.  Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[118]  I. Tesseur,et al.  Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice. , 2000, The American journal of pathology.

[119]  Matthias Orth,et al.  Expression of Human Apolipoprotein E3 or E4 in the Brains ofApoe−/− Mice: Isoform-Specific Effects on Neurodegeneration , 1999, The Journal of Neuroscience.

[120]  J. Gilbert,et al.  Sialylated Human Apolipoprotein E (apoEs) Is Preferentially Associated with Neuron-Enriched Cultures from APOE Transgenic Mice , 1999, Neurobiology of Disease.

[121]  C. Dyer,et al.  An apolipoprotein E synthetic peptide selectively modulates the transcription of the gene for rat ovarian theca and interstitial cell P450 17alpha-hydroxylase, C17-20 lyase. , 1998, Journal of lipid research.

[122]  L. Mucke,et al.  Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[123]  Charles F. Sing,et al.  An ecological study of association between coronary heart disease mortality rates in men and the relative frequencies of common allelic variations in the gene coding for apolipoprotein E , 1998, Human Genetics.

[124]  H. Soininen,et al.  Apolipoprotein E polymorphism in patients with different neurodegenerative disorders , 1996, Neuroscience Letters.

[125]  J. Stengård,et al.  Apolipoprotein E polymorphism, Alzheimer's disease and vascular dementia among elderly Finnish men , 1995, Acta neurologica Scandinavica.

[126]  T. Lehtimäki,et al.  Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women. , 1995, Atherosclerosis.

[127]  J. Stengård,et al.  Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. , 1995, Circulation.

[128]  G. Getz,et al.  Isoform-specific binding of apolipoprotein E to beta-amyloid. , 1994, The Journal of biological chemistry.

[129]  L. Kuller,et al.  Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. , 1993, The American journal of cardiology.

[130]  C. Semenkovich,et al.  A protein partially expressed on the surface of HepG2 cells that binds lipoproteins specifically is nucleolin. , 1990, Biochemistry.

[131]  R. Mahley,et al.  Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. , 1987, Biochimica et biophysica acta.

[132]  B. Danielsson,et al.  Isolation of a high density lipoprotein with high contents of arginine‐rich apoprotein (apoE) from rat plasma , 1978, FEBS letters.

[133]  B. Morrison,et al.  Nuclear uptake of an amino-terminal fragment of apolipoprotein E4 promotes cell death and localizes within microglia of the Alzheimer's disease brain. , 2017, International journal of physiology, pathophysiology and pharmacology.

[134]  Fei Liu,et al.  Tau and neurodegenerative disease: the story so far , 2016, Nature Reviews Neurology.

[135]  Angus C. Nairn,et al.  Protein phosphatases and Alzheimer's disease. , 2012, Progress in molecular biology and translational science.

[136]  K. Winklhofer,et al.  Targeting of the prion protein to the cytosol: mechanisms and consequences. , 2010, Current issues in molecular biology.

[137]  T. Vollmer,et al.  APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis. , 2008, Neurology.

[138]  G. Koutsis,et al.  APOE epsilon4 is associated with impaired verbal learning in patients with MS. , 2007, Neurology.

[139]  Jerzy Majka,et al.  Analysis of protein-DNA interactions using surface plasmon resonance. , 2007, Advances in biochemical engineering/biotechnology.

[140]  Wing Sze Cheung,et al.  Apolipoprotein E epsilon4 allele is associated with vascular dementia. , 2006, Dementia and geriatric cognitive disorders.

[141]  G. Schellenberg,et al.  Reduced Hippocampal Insulin-Degrading Enzyme in Late-Onset Alzheimer's Disease Is Associated with the Apolipoprotein E-ε4 Allele , 2003 .

[142]  B. Winblad,et al.  Effects of apolipoprotein E (apoE) isoforms, beta-amyloid (Abeta) and apoE/Abeta complexes on protein kinase C-alpha (PKC-alpha) translocation and amyloid precursor protein (APP) processing in human SH-SY5Y neuroblastoma cells and fibroblasts. , 2001, Neurochemistry international.

[143]  T. Saido,et al.  Metabolic regulation of brain Abeta by neprilysin. , 2001, Science.

[144]  R. Mahley,et al.  Apolipoprotein E: far more than a lipid transport protein. , 2000, Annual review of genomics and human genetics.

[145]  M. Linton,et al.  The cell biology and physiologic relevance of ApoE recycling. , 2000, Trends in cardiovascular medicine.

[146]  Joakim Bjorkdahl.  Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease. , 2000 .

[147]  R. E. Pitas,et al.  Apolipoprotein E in nerve injury and repair. , 1987, Progress in brain research.